Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.29T
Market cap1.29T
Price-Earnings ratio
43.78
Price-Earnings ratio43.78
Dividend yield
0.52%
Dividend yield0.52%
Average volume
2.39M
Average volume2.39M
High today
$1,408.38
High today$1,408.38
Low today
$1,320.00
Low today$1,320.00
Open price
$1,332.00
Open price$1,332.00
Volume
4.37M
Volume4.37M
52 Week high
$1,408.38
52 Week high$1,408.38
52 Week low
$809.63
52 Week low$809.63

Stock Snapshot

With a market cap of 1.29T, Eli Lilly(LLY) trades at $1,386.00. The stock has a price-to-earnings ratio of 43.78 and currently yields dividends of 0.52%.

During the trading session on 2026-10-29, Eli Lilly(LLY) shares reached a daily high of $1,408.38 and a low of $1,320.00. At a current price of $1,386.00, the stock is +5.0% higher than the low and still -1.6% under the high.

Trading activity shows a volume of 4.37M, compared to an average daily volume of 2.39M.

The stock's 52-week range extends from a low of $809.63 to a high of $1,408.38.

The stock's 52-week range extends from a low of $809.63 to a high of $1,408.38.

LLY News

CNBC 56m
Biopharma stocks climb on Merck and Eli Lilly earnings - CNBC

...

Biopharma stocks climb on Merck and Eli Lilly earnings - CNBC
The Motley Fool 4h
Eli Lilly Sells 53% More at Lower Prices: Rapid Earnings Reaction

Eli Lilly's (LLY +5.97%) third-quarter revenue rose 39% to about $24.4 billion, as a 53% jump in volume swamped a 15% drop in realized prices. Shares were up ab...

Eli Lilly Sells 53% More at Lower Prices: Rapid Earnings Reaction
The Wall Street Journal 7h
Health Care Roundup: Market Talk

george frey / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

Health Care Roundup: Market Talk

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
9.1%
Sell
6.1%

More LLY News

24/7 Wall St. 8h
Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher

Investing Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher Merck (NYSE:MRK | MRK Price Prediction) is t...

Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher
Simply Wall St 9h
Eli Lilly Retatrutide Beat A Rival Drug In Phase 3 Trial

Eli Lilly (NYSE: LLY) reported that retatrutide outperformed Novo Nordisk's Ozempic in a major Phase 3 diabetes trial. The business unveiled plans to combine U...

TipRanks 9h
Eli Lilly Stock Soars as Financial Results Crush Wall Street Estimates

Shares of Eli Lilly (LLY) are up 8% after the pharmaceutical company reported quarterly financial results that trounced Wall Street’s estimates. The Indianapoli...

24/7 Wall St. 9h
Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases

Investing Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases Eli Lilly just posted a quarter that left...

Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases
Benzinga 9h
Eli Lilly Mounjaro Clocks 65% Jump in Sales to Massive $10.7 billion

Eli Lilly and Co. (NYSE:LLY) shares traded higher Thursday after the drugmaker reported better-than-expected third-quarter results, driven by upbeat demand for...

Eli Lilly Mounjaro Clocks 65% Jump in Sales to Massive $10.7 billion
The Wall Street Journal 12h
Eli Lilly Revenue Climbs on Demand for Mounjaro, Zepbound

Eli Lilly’s quarterly revenue jumped on growing demand for its diabetes and obesity drugs. Mike Blake / Reuters Eli Lilly’s LLY 0.50 %increase; up pointing tri...

Eli Lilly Revenue Climbs on Demand for Mounjaro, Zepbound
MarketWatch 12h
Lilly raises outlook for third time this year as Zepbound sales soar.

Eli Lilly had yet another record quarter as sales of its weight-loss injection Zepbound soared. The company also raised its outlook for the third time this yea...

Lilly raises outlook for third time this year as Zepbound sales soar.

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.